Could cause temporary or reversible harm; serious harm is unlikely.
Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly with a BUD of 12/25/2025.
| Distributed by / for | Nubratori, Inc |
| NDC | 71300-6564-1 |
| Full product label | Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12 - 5 mL Single Dose Units per box, Preservative Free, For Iontophoresis Use Only, Non-Sterile Product, Not for Injection, NUBRATORI RX, 381 Van Ness Ave# 1507, CA 90501, NDC 71300-6564-1 (box), 71300-6564-3 (vial). |
| Recalling firm | Nubratori, Inc |
| Distribution | PA and CA. |
| Quantity | 20 boxes |
| Recall initiated | 2025-04-15 |
| Report date | 2025-05-07 |
| Recall completed | — |
| Recall number | D-0392-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Torrance CA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗